Regeneron Pharmaceuticals, Inc.: Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human ...
ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance
Generated record quarterly net revenues of $190.6 million, representing year-over-year growth of 44.8%Total Rare Disease quarterly net revenue of $87.0 million, which includes: Record quarterly ...
ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen
ClearPoint's Q4 updates: neurosurgery growth, expanding services, controlled cash burn and high-potential partner programs ...
Know Labs Announces Approval to Begin Trading on the OTCQB Market
Know Labs, Inc. (OTC: KNWN) a leading innovator in Radio Frequency Dielectric Spectroscopy (RFDS) sensor technology announced today that the Company’s common shares have been approved to quote on the ...